Reassuringly, the combination treatment with AZ produced a more significant reduction in tumor growth and angiogenesis, although the influence of the combined treatment on VEGF and HIF1α pathways remained uninvestigated (Figure 5) [51]. The gene discussed is HIF1A; the disease is neoplasm.